Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
If you've been taking a GLP-1 medication like Ozempic for weight loss and are considering pregnancy, you likely have questions about timing and safety. Semaglutide, the active ingredient in Ozempic, is not recommended during pregnancy, but planning conception after stopping the medication is possible with proper medical support.
How Long After Stopping Ozempic Can You Get Pregnant
Semaglutide has a half-life of approximately one week, meaning it gradually leaves your system over several weeks. Most clinical guidance recommends waiting at least one to two menstrual cycles after your final injection before attempting conception, though individual timelines vary based on dose and treatment duration. This waiting period allows your body to metabolically stabilize and reduces any potential fetal exposure to the medication.
During this transition window, your healthcare provider may recommend lifestyle modifications, prenatal vitamins with folic acid, and baseline metabolic screening. Weight regain during this interim period is common and expected, as the medication's appetite-suppressing effects fade. Working with a provider experienced in fertility and metabolic health can help you navigate this time with realistic expectations and solid planning.
Safety Concerns: Pregnancy and GLP-1 Medications
The FDA has not classified semaglutide as safe for use during pregnancy. Animal studies have shown some developmental effects at high doses, and human pregnancy data remains limited. For this reason, contraception is recommended during active GLP-1 therapy, and conception should be planned only after discontinuation and adequate washout time.
Gestational diabetes risk, maternal weight, and pre-pregnancy metabolic health all influence pregnancy outcomes. Some evidence suggests that achieving a healthier baseline weight before conception—which may have been enabled by prior GLP-1 therapy—can improve obstetric outcomes. Your obstetrician should be informed of your prior medication history so they can adjust monitoring and glucose screening accordingly.
Metabolic Changes and Fertility After GLP-1 Therapy
GLP-1 medications improve insulin sensitivity and reduce inflammation, changes that often persist even after stopping therapy. Some women report improved menstrual regularity and fertility markers after weight loss achieved with semaglutide, potentially offsetting natural fertility decline associated with obesity. These metabolic improvements may actually enhance fertility potential in individuals with PCOS or other weight-related reproductive disorders.
However, rapid weight regain after stopping GLP-1 therapy can temporarily disrupt hormonal balance and ovulation. Maintaining the lifestyle habits developed during treatment—such as consistent physical activity and protein-rich nutrition—helps stabilize metabolic health during the transition to conception. A fertility specialist can assess ovulation patterns and hormone levels if conception does not occur within 6–12 months of stopping medication.
Planning Your Pregnancy Journey With PlexusDx Support
PlexusDx offers compounded semaglutide injections starting at $149 per month through licensed 503A pharmacies, making targeted weight management accessible as you plan your reproductive timeline. If you are currently taking GLP-1 therapy and considering pregnancy, your PlexusDx provider can help coordinate your transition plan with your obstetrician to ensure safe discontinuation and appropriate medical follow-up.
The Precision Peptide Genetic Test available through PlexusDx ($99 add-on after your first month of treatment) identifies genetic variations in GLP1R, GIPR, FTO, and MC4R pathways that influence weight loss response and metabolic health. Understanding your individual peptide pathway profile can inform long-term weight management strategies before, during, and after pregnancy, helping you maintain the health gains achieved through prior therapy. PlexusDx serves all 50 states with no insurance required and HSA/FSA eligibility, making personalized metabolic guidance affordable and accessible.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How long should I wait after my last Ozempic injection to try to get pregnant?
Most providers recommend waiting one to two menstrual cycles after your final dose to allow semaglutide to clear your system. Your OB-GYN or fertility specialist should confirm timing based on your individual dose and treatment history. PlexusDx can coordinate with your obstetric team to ensure a safe transition plan.
Will stopping GLP-1 therapy cause me to regain weight before I get pregnant?
Weight regain is common after stopping GLP-1 medications, but lifestyle habits developed during treatment often persist. Maintaining exercise, protein intake, and stress management during your transition period can slow regain and support metabolic health as you prepare for conception.
Can I use PlexusDx compounded semaglutide while planning pregnancy?
PlexusDx compounded semaglutide injections (starting at $149/month) can be used for weight loss leading up to your planned conception date. Once you decide to attempt pregnancy, you and your provider should plan a discontinuation timeline, typically 1–2 cycles before conception.
Are there any risks to my baby if I accidentally take GLP-1 medication early in pregnancy?
While semaglutide is not recommended in pregnancy, limited accidental exposures early in gestation have not shown clear evidence of fetal harm in human data. However, if this occurs, notify your OB-GYN immediately for counseling and monitoring.
How can the PlexusDx Precision Peptide Genetic Test help me plan pregnancy after GLP-1 therapy?
The Precision Peptide Genetic Test ($99 add-on) analyzes variants in GLP1R, GIPR, FTO, and MC4R pathways to reveal your unique metabolic predispositions.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Semaglutide Make You Lose Weight Without Dieting?
Tirzepatide for Weight Loss: Can You Take It Without Diabetes?